BJL
MXCT icon

Brighton Jones LLC’s MaxCyte MXCT Stock Holding History

Brighton Jones LLC’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.7K Buy
24,157
+13,133
+119% +$13.1K ﹤0.01% 1388
2026
Q1 		$7.75K Buy
+11,024
New +$10.3K ﹤0.01% 1197

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $2.1B AUM 24.61% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Brighton Jones LLC's MXCT Position: Q2 2026 in Review

Brighton Jones LLC increased its MaxCyte (MXCT) stake by 119% in Q2 2026, buying an estimated $13.1K and bringing the position to 24,157 shares worth $29.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1388.

Brighton Jones LLC first reported a position in MXCT in Q1 2026 and has held it in 2 quarters since. 55 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Brighton Jones LLC held 24,157 shares of MaxCyte worth $29.7K as of Q2 2026.
  • Brighton Jones LLC bought 13,133 MaxCyte shares in Q2 2026, an estimated $13.1K.
  • MaxCyte made up ﹤0.01% of Brighton Jones LLC's portfolio in Q2 2026, its #1388 holding.
  • Brighton Jones LLC first reported a position in MaxCyte in Q1 2026 and has held it in 2 quarters since.
  • 55 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Brighton Jones LLC's 13F filing for Q2 2026, filed 11 Aug 2026.